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INTRODUCTION
In the mature animal, a variety of stressors activate the hypothalamic-pituitary-adrenal
(HPA) axis:1–3 Increased secretion of corticotropin-releasing hormone (CRH) from the
hypothalamic paraventricular nucleus (PVN) induces ACTH release from the pituitary and
increases plasma corticosterone (CORT). The depletion of hypothalamic CRH is followed
by a “compensatory” up-regulation of CRH gene expression.2–4 Limbic input from
hippocampus and amygdala, mainly the central nucleus (ACE), further modulates stress-
induced alteration of CRH gene expression.5,6
The presence of most of these components of the “stress response” in the neonatal (first
postnatal week) and infant (second postnatal week) rat has been debated.7,8 Elevation of
plasma glucocorticoids in response to stressors and the relative roles of CRH and
vasopressin have been subjects of investigation.4,7–10 A “stress-hypo-responsive” period
with diminished or immature hormonal responses has been described during the first two
postnatal weeks.
The goal of this report is to present data confirming the presence of robust stress-induced
elevation of plasma glucocorticoids (GC) and the involvement of CRH in this response.
Evidence for immature regulation of CRH gene expression by GC and stress will be




Pups were products of time-pregnant Sprague-Dawley rats (Zivic-Miller, Zeliehople, PA),
kept on a 12-h light/dark cycle and given access to unlimited lab chow and water. Delivery
was verified at 12-h intervals, and the date of birth was considered day 0. Litters were culled
to 12 pups, and undisturbed for 48 h prior to experiments. All experiments were started at 9
A.M. to avoid circadian variation in HPA axis components and tone.1,11
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Dibutyryl-cyclic-AMP (db-cAMP), isobutyl methylxanthine (IBMX), dexa-methasone
(DEX), forskolin, and GTP were obtained from Sigma Chemical Co. (St. Louis, MO). DEX
was dissolved in 100% ethanol, and forskolin was dissolved in DMSO. Stock solutions of
both drugs were diluted with 102 to 106 volumes of buffer immediately prior to use. CRH
antiserum (CRH-AS) produced in sheep was a gracious gift of Dr. W. W. Vale (pool No.
238-293). Normal sheep serum (NSS) was purchased from Calbiochem (San Diego, CA).
CRH-antagonist, (9-41)-alpha-helical CRH, was purchased from BACHEM (Torrance, CA).
Stress Paradigm and Hormonal Studies
Acute cold-separation was chosen as a potent, age-specific and painless stress.4,10 Pups were
separated from their mothers and placed individually in glass jars in a cold room (4 °C).
Preliminary experiments defined maximally tolerated cold exposure, as defined by the
development of rigor and little response to tactile stimulus (core temperature averaged 9.8
°C). Thus, cold exposure lasted an average of 30 min in 4–6-day-old pups and 60 min in 11–
16-day-old pups. Stressed pups were rewarmed on a heating pad under a heat lamp as a
group. Rats were sacrificed by decapitation and trunk blood was collected before the onset
of stress and at 0, 20, 40 (or 30), 60, 150, and 240 min after its termination. Control rats
were left in home cages and sacrificed within 45 s of disturbance. Plasma CORT levels were
determined by radioimmunoassay (ICN, Irvine, CA). Assay sensitivity was 0.5 μg/dL;
interassay variability was determined by two dilutions of adult rat plasma, and averaged
15%.4,10
CRH-Antiserum Effect on Stress-Induced Plasma CORT Elevation
Rat pups were divided into the following experimental groups: undisturbed controls,
injection controls, cold exposure, cold and NSS-injection and cold and CRH-AS injection.
Rats were injected with CRH-AS or NSS (100 μL, ip) at 9:30 A.M. One hour later, rats were
exposed to cold for 25 min (6-day-old) or 40 min (9-10-day-old), rewarmed for 50 min and
sacrificed. Undisturbed controls were sacrificed at 9 A.M. and injection controls (not exposed
to cold) immediately prior to the corresponding cold-exposed groups.
Time-Course of and Age Dependence of Stress-Induced Up-Regulation of CRH-mRNA
Abundance
In a preliminary time-course experiment, 16-day-old-rats were divided into six groups (n =
4). Groups 1–3 were subjected to cold-separation stress as above, and sacrificed at 1, 4, or
28 h after termination of stress. Groups 4–6 served as controls for both separation-cold stress
and diurnal variability in CRH-mRNA.11 Controls were undisturbed in home cages until
sacrifice at the corresponding hours. Based on the results of this experiment,4 6-, 9- and 16-
day-old rats were subjected to cold-separation stress as above, and decapitated 4 or 28 h
after the onset of cold-stress (the 28-h group was returned to home cages at 4 h and
sacrificed 24 h later).
Effect of db-cAMP on Stress-Induced CRH Synthesis in the 6-Day-Old Rat
Six-day-old rats were assigned to one of the following groups: (1) Undisturbed controls; (2)
cold-stressed controls; (3) cannulated, saline-infused, stressed controls; (4) cannulated, db-
cAMP-infused, stressed; and (5) cannulated, stressed, with db-cAMP infused into the
striatum. Cold was used as both stressor and anesthetic. Rats were placed in an ice-bath and
transferred to a stereotaxic apparatus when motionless. Stainless steel cannulae were
implanted unilaterally, with the tip directed immediately above the PVN.12,13 We have
previously shown that in the neonatal rat, a unilateral infusion of a number of compounds
results in diffusion to the contralateral PVN (refs. 12 and 13 and unpublished observations).
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Coordinates for striatal cannulae were A: 0.95, V: 4.0, L: 3.4 in reference to bregma. Saline
or db-cAMP (1 μmole in 1 μL) was infused using a Hamilton syringe. Cannula placement
was verified in each animal using 20-μm coronal sections stained with cresyl violet.
Methodology of cAMP Analysis
Rats were sacrificed at 9 A.M., and brains were removed within 45 s of initial disturbance.
Anterior hypothalami were dissected on ice as follows: The brain was placed, hypothalamus
up, on an ice-chilled petri dish. With a razor blade, a coronal cut was made 2 mm (for
immature) or 2.5 mm (for adult rats) anterior to the mammillary bodies. Diagonal cuts
separated the hypothalamus, including the medial preoptic area, from the telencephalon. A
horizontal cut, 3 mm above the inferior surface of the hypothalamus separated it from the
thalamus. The resultant tissue-block, as determined in preliminary experiments, consisted of
the PVN, periventricular and medial preoptic nuclei, and the anterior hypothalamic area.
Dissection was achieved in 20 s or less, and the weight of the excised block averaged 19.8 ±
0.8 mg. Dissected tissues were immediately transferred to ice-chilled buffer, pooled, and
minced to a thickness of 300–400 μm. Minced tissue was suspended in 50 vol of freshly
oxygenated Krebs buffer (NaCl; 119, KC1; 2.5, MgSO4; 1.3, CaCl2; 2.5, KH2P04; 1.0,
NaHC03; 26.2, glucose; 11 raM, pH 7.4) containing 0.5 mM IBMX and 0.1 μM GTP, and
incubated for 30 min at 37 °C. During preincubation, medium was replaced with equal
volume of freshly oxygenated buffer. Tissue aliquots were portioned into test tubes
containing fresh buffer with various concentrations of DEX for an initial incubation of 20
min at 37 °C, and then pipetted into chambers containing fresh buffer and desired
concentrations of forskolin and DEX for a final 15 min. Incubation was terminated by
transferring chambers onto ice and pipetting the tissue into test tubes containing 500 μL of
ice-cold 10% trichloroacetic acid. Homogenization (on ice) and centrifu-gation (1,000 × g
for 10 min) were followed by extraction of supernatants with 5 vol of diethyl ether (3x).
Supernatants were lyophilized and stored at −20 °C until used for cAMP assay. Pellets were
resuspended in 50 mM sodium acetate buffer and assayed for protein. cAMP
radioimmunoassay was performed using commercial cAMP tracer (Biomedical
Technologies Inc., Stoughton, MA) and cAMP antibody obtained from the National
Institutes of Health. Assay sensitivity was 0.05 pmol/mL.
Tissue Processing and in Situ Hybridization
In all experiments, brains were rapidly removed onto powdered dry ice and stored at −80 °C.
Brains were cut into 20-μm coronal sections in a cryostat and mounted on gelatin-coated
slides.14,15 Preparation of oligonucleotides for CRH and CRF1, and details of ISH and
image analysis have been described.4,10,12,14,15 Briefly, prior to in situ hybridization (ISH),
slides were brought to room temperature, air-dried and fixed in buffered paraformaldehyde.
Following a graded ethanol treatment, sections were exposed to acetic anhydride-
triethanolamine, then dehydrated through 100% ethanol. Sections were prehybridized for 1
h, then hybridized for 20 h at 40 °C in a humidity chamber. Serial washes (2× SSC for 15
min x4 at 40 °C; lx and 0.3× SSC for 30 min each at room temperature) were followed by
dehydration and apposition to film (Hyperfilm B-Max, Amersham). Selected sections were
subsequently dipped in emulsion (NTB-2; Kodak), and developed as previously described,
with the exception that the emulsion was not diluted.
Analysis
Quantitation and statistical analysis were described previously.4,12,14,15 Briefly, optical
density (OD) was determined over areas of interest, using the MCID software image
analysis system (Imaging Research, Ont., Canada). Each point was derived from 6–12
sections from a minimum of four individual rats. Statistical significance between groups was
determined using two-way analysis of variance, followed by Duncan’s multiple range tests.
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Cold-Separation Stress Elevates Plasma CORT throughout the First Two Postnatal Weeks
The time course and magnitude of cold-induced CORT elevation are shown in Figure 1.
Clear, stress-induced peaks of plasma CORT were evident on postnatal days (PND) 4–6, 9,
and 11–13. Maximal cold–stress induced plasma CORT values were 7.57 ± 0.86, 6.48 ±
0.26, and 6.64 ± 1.31 (μg/dL on PND 6, 9, and 11–13, respectively.
Cold-Stress-Induced Elevation of Plasma CORT Is Abolished by Antiserum to CRH
Injection of either AS or NSS resulted in increased plasma CORT, presumably because of
handling and pain. Cold-separation stress induced a significant (p < 0.01) further increase in
plasma CORT levels at both days 6 and 9 (Fig. 2A and 2B). At both ages, administration of
CRH-AS abolished cold-induced plasma CORT (p < 0.01, cold + NSS vs. cold + AS).
Stress Induces CRH Gene Expression Only in 9-Day, or Older, Rats
A significant increase of CRH-mRNA abundance in the PVN of 16-day-old rats was
observed at 4 h (but not at 1 h), and persisted at 28 h subsequent to cold-separation stress.
Therefore, these time points were studied in younger rats. In 9-day-old rats, cold-separation
stress enhanced CRH-mRNA abundance at 4 h, but not at 28 h. No change in the CRH-
message was found in 6-day-old rats (Fig. 3).
Infusion of a Cyclic AMP Analogue Enables the Up-Regulation of CRH Synthesis by Stress
in the 6-Day-Old Rat
As is evident from Figure 4, infusion of db-cAMP permitted cold stress to up-regulate CRH
gene expression in response to cold stress. This was evident upon infusion of the cAMP
analogue to the PVN. Striatal infusion of db-cAMP was ineffective (not shown). db-cAMP
was thus able to “reconstitute” a missing regulatory factor(s) acting on the CRH gene
promoter.
The Regulation of cAMP by Glucocorticoids Is Deficient in Immature Rat Hypothalamus
Anterior hypothalami derived from adult rats contained less basal cAMP (pmole/mg protein)
than those of neonatal rats (Fig. 5A). This was probably due to higher protein concentrations
in the adult rat. DEX alone (0.01 μM to 10 μM) did not significantly affect cAMP content at
any age (Fig. 5A). Forskolin (10 μM) stimulated adenylate cyclase in the anterior
hypothalamus significantly in all age groups (Fig. 5B). A 10-fold increase in cAMP
production was found in adult rats, and a 3.2- to 6-fold increase in neonatal rats (3- to 13-
day-old, p < 0.05).
DEX inhibited the stimulatory effect of forskolin on adenylate cyclase in the anterior
hypothalamus of adult rats in a concentration-dependent manner, with maximal effect (a
60% reduction) observed with 1 μM. This inhibitory effect of dex was considerably reduced
in the anterior hypothalamus of 9- to 13-day-old rats, and was minimal in 3- to 4-day-old
rats (Fig. 5C). Data analysis revealed a significant effect of age (p < 0.05), IC50’s of the
inhibition curves for the adult and 9- to 13-day-old rats were 1.87 ± 0.4 × 10−8 M and 1.68 ±
0.32 × 10−7 M, respectively.
CRH Receptor Is Highly Abundant in Limbic Structures of the Immature Rat
Figure 6 is a schematic representation of the CRH receptor (CRF1) messenger RNA
distribution in hippocampus, amygdala, and cortex of the developing rat. Hippocampal
values are a composite of CA1–CA2 and CA3 values.16 Amygdala values represent
primarily the basolateral and central nuclei. Cortex was sampled at the frontoparietal
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convexity. Maximal receptor levels in the hippocampus are evident on PND 6 and peak in
amygdala on PND 9.
DISCUSSION
The hormonal response to stressful cues is complex. The final common pathway consists of
a transient, CRH-induced elevation of plasma ACTH and CORT. Negative feedback effects
of glucocorticoids, which help terminate the response, up-regulation of CRH gene
expression after stress-induced “depletion” of hypothalamic stores, and limbic input
impinging on the hypothalamic PVN are only some of the molecular events contributing to
this complex adaptive mechanism.1–6
During the neonatal and infant developmental periods in the rat, “immaturity” of this
hormonal stress response implies quantitative or qualitative alterations of one or more
components of this chain of events.4,7–10 The specific control points at which the immature
animal differs from the adult are unclear. Obviously, perturbation of regulation of CRH gene
expression, for example, should result in significant alteration of “downstream” components
such as plasma CORT.
The studies described affirm that cold, a defined, age-specific acute stress, induces plasma
CORT throughout the neonatal and infant period. Further, this elevation of plasma CORT
depends on CRH in that it is abolished by antiserum to the peptide. As such, no major
qualitative difference exists between the neonatal and adult rat in the “effector” arm of the
CRH-CORT cascade.
Stress-induced up-regulation of CRH synthesis does not occur to any significant degree
prior to the second postnatal week. This is consistent with previous findings regarding
“insensitivity” of the CRH gene promoter, in vivo, in the neonatal rat.12 Neither the
elimination of negative glucocorticoid feedback, by blocking of GC receptors in the PVN,
nor the chronic stress of surgical cannula implantation resulted in increased steady-state
CRH-mRNA prior to the ninth day of life.12 Both maneuvers increased CRH gene
expression in the PVN of older rats.12
Candidate mechanisms for this insensitivity of the CRH gene promoter in the neonatal rat in
vivo are suggested in Figures 4 and 5. First, infusion of a cAMP analogue, dibutyryl-cAMP,
into the PVN during cold-surgery stress on PND 6, permitted enhancement of CRH-mRNA
abundance, an effect normally observed on PND 9 or later. The effect was specific to db-
cAMP and was not observed upon saline infusion. Further, neither db-cAMP nor saline was
effective upon infusion into the striatum, suggesting anatomic specificity to the
hypothalamus. A similar approach, implicating cAMP in the regulation of neuropeptide Y
has recently been reported.17 The mechanism by which db-cAMP, in conjunction with acute
stress, enhanced CRH-mRNA abundance on PND 6 remains speculative. The rationale for
infusing the cAMP analogue derives from the fact that the CRH gene promoter contains a
cAMP response element (CRE).18–20 Forskolin enhances the human CRH gene promoter,
and mutation of the CRH-CRE sequence completely abolishes the stimulation by cAMP.19
We speculated that the cAMP-dependent signal transduction pathway might not be fully
functional on PND 6. An excess of exogenous cAMP enabled this “mature response” of the
CRH promoter on PND 6, consistent with a role for cAMP in the activation of the CRH
gene promoter.
Additionally, the interaction between GC and the cAMP second messenger cascade is
altered in the developing hypothalamus (Fig. 5A–C).21 A consensus GC response element
sequence is not found at, or upstream from, the CRH gene promoter site, suggesting other
mechanisms for the observed down-regulation of CRH synthesis by GC in the adult.20 We
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find that GC decreases cAMP production in mature hypothalamus.21 The response curve is
shifted markedly to the right in the neonatal or infant rat (Fig. 5C).
An additional determinant of the magnitude of the CRH effect is the presence and
abundance of receptors mediating the peptide’s effects.22–24 In the immature rat, distinct
temporal and spatial profiles of one of these receptor types, CRF1, is clearly evident. For
example, on the sixth postnatal day, the hippocampal/amygdala receptor ratio is higher than
on the ninth postnatal day or in the adult. Whether this may result in augmented inhibitory
input from hippocampus to PVN at this age remains speculative.16
SUMMARY
The ability to respond to adverse environmental cues is present in the neonatal and infant
rat, although in an immature form: A number of laboratories have demonstrated stress-
induced elevations of plasma glucocorticoids during the first two postnatal weeks. The
limbic and hypothalamic mechanisms controlling the hormonal stress-response during this
period are not fully understood and are, therefore, the focus of this report.
Both hypothalamic corticotropin-releasing hormone (CRH) and vasopressin contribute to the
release of ACTH from the pituitary in the adult. The relative roles of these two peptides
during the neonatal (first week) and infant (second week) developmental period, are
controversial. Evidence is presented that argues strongly for a major role for CRH.
Up-regulation of hypothalamic CRH synthesis is a major component in the mature stress
response. CRH-mRNA levels in the hypothalamic PVN are increased with cold stress by the
ninth postnatal day, but not during the first postnatal week. Further, down-regulation of
CRH gene expression by glucocorticoids (GC) constitutes a critical “shut-down” mechanism
for the hormonal stress response. In vivo and in vitro experiments supporting the
“immaturity” of GC feedback on CRH synthesis during the first postnatal week are
described.
CRH-mediated neurotransmission, in both the endocrine and neuronal effector arms of the
response to stress may be modeulated via alteration of receptor number. The first member of
the CRH receptor family, CRF1, probably mediates the neuroendocrine effects of CRH. The
developmental profile of CRF1-mRNA reveals several distinctive spatial and temporal
patterns. In the hippocampal CA1, CA2, and CA3a, peak (300–600% adult values) CRF1-
mRNA is found on postnatal day 6. In the amygdala, CRH receptor mRNA levels are
maximal on the ninth postnatal day (at 180% of adult values). In cortex, a steady decline
from high postnatal day 2 levels results in adult levels by day 12. These findings
demonstrate distinct, regional, age-specific control of the synthesis of CRF1. Receptor
expression profile may provide important information regarding modulation of the age-
specific roles of CRH in different regions. For example, a high ratio of hippocampus/
amygdala receptors may preferentially activate negative hippocampal input to the
hypothalamus during the neonatal period. Additionally, increased CRH receptor mRNA in
the infant compared with the adult provides a mechanism for enhanced excitatory effect of
the peptide at this age.
In conclusion, increasing evidence exists for multiple control points of the early postnatal
response and adaptation to stress. CRH synthesis in hypothalamus and amygdala, its
sensitivity to GC feedback, and the abundance and distribution of at least two distinct CRH
receptors in the limbic central nervous system and the pituitary are developmentally
regulated. All serve as control points permitting an effective endocrine, autonomic, and
behavioral response to stressful environmental cues.
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Plasma CORT time courses in response to coid-separation stress in 4- to 6-, 9-, and 11- to
13-day-old rats. Values are mean ± SEM of 6–8 rats/group. For all age groups, 60-min
values are significantly different from prestress ones (p < 0.05). On postnatal day 6, the 40-
min value is significantly elevated as well (p < 0.05).
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Effect of passive immunization against CRH on cold-separation stress-induced plasma
CORT. Panel A: On postnatal day 6. Panel B: On postnatal day 9. NSS, normal sheep
serum; AS, antiserum directed against CRH. n = 6 per group. Bars indicate standard errors.
*Significantly different from control (p < 0.05); **significantly different from cold + NSS
(p < 0.05).
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Effect of cold-separation stress on CRH-mRNA in the paraventricular nucleus of 6-(panel
A) and 9-(panel B) day-old rats. Pups were subjected to age-appropriate maximal tolerated
cold-stress. CRH-mRNA was determined using in situ hybridization. Values (mean ± SEM)
were derived as detailed in the Methods section. *Significantly different from control (p <
0.05).
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The effect of db-cAMP infusion, combined with cold + surgical stress, on CRH-mRNA
abundance in the paraventricular nucleus of the 6- and 9-day-old rats. In the 6-day-old,
stress alone did not result in “compensatory” increase of CRH-mRNA abundance at 4 h. db-
cAMP enabled this effect, seen normally in the 9-day-old. In the 9-day-old rat, db-cAMP
further increased stress-induced elevation of steady-state CRH-mRNA levels. *Significantly
different from control (p < 0.05); **different from cold stress.
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(A) Basal cAMP content (pmole/mg protein) in the anterior hypothalamus of neonatal and
adult rats. Dexamethasone alone did not significantly affect cAMP accumulation at any age.
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Values represent the mean ± SEM of 6–7 experimental pools (10–12 neonatal or 2 adult
hypothalami/pool. (B) Forskolin-stimulated adenylate cyclase in the anterior hypothalamus
of neonatal and adult rats. Forskolin (2-20 μM) caused a robust increase at all ages. Values
are the mean ± SEM of 5–6 pooled experiments. (C) Effect of dexamethasone on forskolin-
induced increase in adenylate cyclase in anterior hypothalamus of neonatal and adult rats. *p
< 0.05 vs. forskolin alone. Values obtained from 5–6 pooled experiments. Fors, forskolin;
Dex, dexamethasone.
BARAM et al. Page 14














Schematic of the developmental profile of corticotropin-releasing hormone receptor (CRF1)
in the amygdala, hippocampus, and cortex of the rat. See reference 16 for methodology.
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